Search

Now showing items 1-2 of 2

Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice.

Phillips, AN; Dunn, D; Sabin, C; Pozniak, A; Matthias, R; Geretti, AM; Clarke, J; Churchill, D; Williams, I; Hill, T;... (2005-03-25)

BACKGROUND: Little is known about the long term risk of development of HIV-1 drug resistance for patients starting antiretroviral therapy (ART) with three or four drug regimens in routine clinical practice. METHODS: We ...

A double-blind, crossover study of Biotène Oralbalance and BioXtra systems as salivary substitutes in patients with post-radiotherapy xerostomia.

Shahdad, SA; Taylor, C; Barclay, SC; Steen, IN; Preshaw, PM (2005-09)

This study assessed the efficacy of the Bioxtra (BX) and Biotène Oralbalance (OB) systems in the treatment of post-radiotherapy xerostomia. In a double-blind, crossover study, 20 patients with post-radiotherapy xerostomia ...